However, our pooled results indicate that there are no significant differences in peripheral IGF‐1 levels between antipsychotic naïve or free schizophrenia patients, as well as between schizophrenia patients regardless of the antipsychotic treatment status and healthy controls. This evidence concerns the gene IGF1 and schizophrenia.